Can chronic inflammation blunt HPA axis signaling and raise ferritin while restricting tissue iron?

The physiological relationship between chronic inflammation, endocrine signaling, and iron metabolism is well-documented. Research indicates that persistent inflammatory states can fundamentally alter the Hypothalamic-Pituitary-Adrenal (HPA) axis and skew traditional markers of iron status, such as ferritin.

HPA axis signaling and cortisol responsiveness

Chronic exposure to pro-inflammatory cytokines, particularly IL-6, TNF-α, and IL-1β, is a primary driver of HPA axis dysfunction. While acute inflammation typically stimulates cortisol production to manage stress, prolonged inflammation leads to a state of blunted responsiveness.

• Central Inhibition: High levels of cytokines directly inhibit the release of corticotropin-releasing hormone (CRH) from the hypothalamus and adrenocorticotropic hormone (ACTH) from the pituitary. This suppression is often mediated by neuronal-microglial crosstalk and the activation of the NLRP3 inflammasome.
• Glucocorticoid Resistance: Cytokines impair the cellular response to cortisol by interfering with glucocorticoid receptor (GR) function. Mechanisms include reducing GR nuclear translocation and shifting production toward the inactive GR-β isoform, which prevents cortisol from exerting its anti-inflammatory effects even when present in the bloodstream.
• Steroidogenic Suppression: Prolonged inflammation can downregulate the expression of key adrenal steroidogenic enzymes, directly limiting the body’s capacity to synthesize cortisol.

Ferritin as an acute-phase reactant

Ferritin serves as more than just an iron storage protein; it is a critical acute-phase reactant that increases during systemic inflammation, often masking true iron status.

• Inflammatory Induction: Cytokines like IL-6 and IL-18 stimulate ferritin production independently of the body's actual iron stores. In inflammatory states, ferritin levels can remain elevated (often exceeding 100–300 µg/L) even if cellular iron is scarce.
• Hepcidin-Mediated Sequestration: Inflammation triggers the release of hepcidin, which degrades ferroportin—the only known channel for iron export from cells. This locks iron inside macrophages and the liver, restricting its availability for essential processes like red blood cell production.
• Functional Iron Deficiency: This state, known as "anemia of chronic disease," is characterized by high ferritin alongside low transferrin saturation (TSAT <20%). In these cases, the body has "locked away" its iron, making it unavailable to tissues despite high storage markers.

Bottom line

Chronic inflammation suppresses the HPA axis through central inhibition and peripheral receptor resistance while simultaneously elevating ferritin through the acute-phase response. This creates a clinical scenario where cortisol responsiveness is diminished and tissue iron availability is restricted, despite potentially high ferritin levels.